OAB-050: Randomized phase 2 study of weekly carfilzomib 70 mg/m2 and dexamethasone plus/minus cyclophosphamide in relapsed and/or refractory multiple (MM) patients (GEMKyCyDex)
Titel:
OAB-050: Randomized phase 2 study of weekly carfilzomib 70 mg/m2 and dexamethasone plus/minus cyclophosphamide in relapsed and/or refractory multiple (MM) patients (GEMKyCyDex)
Auteur:
Puertas, Borja González, Verónica Sureda, Anna Moreno, Mª José Oriol, Albert González, Mª Esther Rosiñol, Laura López, Jordi Escalante, Fernando López, Joaquín Martinez Carrillo, Estrella Clavero, Esther Rodríguez, Ana Pilar González Dourdil, Victoria de la Fuente, Felipe de Arriba González, Marta Sonia de Oteyza, Jaime Pérez Hernández, Miguel teodoro Mateo, Aránzazu García Blade, Joan Palacios, Juan José Lahuerta San-Miguel, Jesus Ocio, Enrique Mateos, María-Victoria